Results 11 to 20 of about 23,952,755 (264)

The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors [PDF]

open access: goldFrontiers in Oncology, 2013
Proteoglycans and in particular the syndecans are involved in the differentiation process across the epithelial-mesenchymal axis, principally through their ability to bind growth factors and modulate their downstream signalling.
Tünde eSzatmári, Katalin eDobra
doaj   +2 more sources

High Preoperative Serum Syndecan-1, a Marker of Endothelial Glycocalyx Degradation, and Severe Acute Kidney Injury after Valvular Heart Surgery [PDF]

open access: goldJournal of Clinical Medicine, 2020
Degradation of endothelial glycocalyx (EG) is associated with inflammation and endothelial dysfunction, which may contribute to the development of acute kidney injury (AKI). We investigated the association between a marker of EG degradation and AKI after
Hye-Bin Kim   +5 more
openalex   +2 more sources

Elevated plasma syndecan-1 as glycocalyx injury marker predicts unfavorable outcomes after rt-PA intravenous thrombolysis in acute ischemic stroke

open access: yesFrontiers in Pharmacology, 2022
Purpose: We aimed to examine the prognostic value of syndecan-1 as a marker of glycocalyx injury in patients with acute ischemic stroke (AIS) receiving rt-PA intravenous thrombolysis.Methods: The study included 108 patients with AIS treated with rt-PA ...
Fangfang Zhao   +20 more
doaj   +2 more sources

Measuring the Concentration of Serum Syndecan-1 to Assess Vascular Endothelial Glycocalyx Injury During Hemodialysis

open access: yesFrontiers in Medicine, 2021
Glycocalyx is present on the surface of healthy endothelium, and the concentration of serum syndecan-1 can serve as an injury marker. This study aimed to assess endothelial injury using serum syndecan-1 as a marker of endothelial glycocalyx injury in ...
Keigo Kusuzawa   +36 more
doaj   +2 more sources

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.

open access: yesPLoS ONE, 2021
The endothelial glycocalyx (EG) is essential for proper function of the endothelium and for vascular integrity, but its role in premature atherogenesis in rheumatoid arthritis (RA) has not been studied yet.
Gia Deyab   +10 more
doaj   +2 more sources

Serum Syndecan-1 is Associated With Kidney and Cardiovascular Outcomes in Idiopathic Nephrotic Syndrome [PDF]

open access: yesKidney International Reports
Introduction: Idiopathic nephrotic syndrome (INS) is associated with important kidney and cardiovascular morbidities. We tested the hypothesis that serum syndecan-1, a marker of endothelial glycocalyx injury, can help identify patients at risk for ...
Colin Bauer   +10 more
doaj   +2 more sources

Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival

open access: yesPLoS ONE, 2021
Syndecan-1 is found in the endothelial glycocalyx and is released into the bloodstream during stressed conditions, including severe diseases such as acute kidney injury, chronic kidney disease, and cardiovascular disease.
Yuichiro Kitagawa   +29 more
doaj   +4 more sources

A novel role for syndecan-3 in angiogenesis [v1; ref status: indexed, http://f1000r.es/2g6] [PDF]

open access: yesF1000Research, 2013
Syndecan-3 is one of the four members of the syndecan family of heparan sulphate proteoglycans and has been shown to interact with numerous growth factors via its heparan sulphate chains.
Giulia De Rossi, James R. Whiteford
doaj   +5 more sources

Cleavage of Syndecan-1 Promotes the Proliferation of the Basal-Like Breast Cancer Cell Line BT-549 Via Akt SUMOylation

open access: yesFrontiers in Cell and Developmental Biology, 2021
Basal-like breast cancer is characterized by an aggressive clinical outcome and presence of metastasis, for which effective therapies are unavailable.
Satomi Nadanaka   +2 more
doaj   +2 more sources

Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas [PDF]

open access: goldAnalytical Cellular Pathology, 2018
Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas ...
Ramón G. Carreón-Burciaga   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy